ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence in improving patient outcomes and managing costs. The editorial highlights ECGI’s acquisition of Avanta Group, a developing integrated healthcare platform encompassing Medicare Advantage insurance, management services, AI-enabled technology, consumer health and healthcare infrastructure. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in 2024, with Medicare Advantage payments projected to total $574 billion in 2026. The editorial also discusses the potential for integrated technology and care coordination to improve efficiency, patient engagement and access to services.
AINewsWire Editorial Coverage : American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc . (OTC: ECGI) ( profile ) has completed its acquisition of Avanta Group, a developing platform that spans a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition gives ECGI a direct path into coordinated, proactive care just as the industry is searching for better ways to deliver it. ECGI is working alongside others operating in the U.S. managed healthcare ecosystem, including industry leaders such as United Health Group Inc. (NYSE: UNH), CVS Health Corporation (NYSE: CVS), Elevance Health Inc. (NYSE: ELV) and…
AUSTIN, Texas, Oct. 19, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc. (OTC: ECGI) (profile) has completed its acquisition of Avanta Group, a developing platform that spans a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition gives ECGI a direct path into coordinated, proactive care just as the industry is searching for better ways to deliver it. ECGI is working alongside others operating in the U.S. managed healthcare ecosystem, including industry leaders such as United Health Group Inc. (NYSE: UNH), CVS Health Corporation (NYSE: CVS), Elevance Health Inc. (NYSE: ELV) and Humana Inc. (NYSE: HUM).
Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs.
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financia...
What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per sha...
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m...
Cancer care is often overwhelming, not just medically, but emotionally and logistically. Elevance Health is strengthening its connected cancer care model to enhance support consumers receive throughout their care journeys, with a focus on earlier support, personalized care navigation, and more coordinated care.
UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Boudreaux's stake now totals ~172,000 directly held shares worth $63.51 million, as Elevance maintains an $80 billion market cap and $5.0 billion in trailing net income.
